CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Abnova (Taiwan) Corporation Company Snapshot
Abnova (Taiwan) Corporation operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abnova (Taiwan) with three other companies in this sector in TAIWAN : Genmont Biotech Inc (2020 sales of 325.19 million Taiwanese Dollars [US$11.63 million] of which 100% was Jingyue Company), Bionet Corp. (806.58 million Taiwanese Dollars [US$28.85 million] ), and Mycenax Biotech Incorporated (665.34 million Taiwanese Dollars [US$23.80 million] of which 68% was Technical Service Income).

Sales Analysis. During the year ended December of 2020, sales at Abnova (Taiwan) were 456.45 million Taiwanese Dollars (US$16.33 million). This is an increase of 10.2% versus 2019, when the company's sales were 414.16 million Taiwanese Dollars . The sales level in 2020 was fairly close to the level five years ago: in 2015, Abnova (Taiwan) had sales of 451.37 million Taiwanese Dollars . Sales of Paired Antibodies saw an increase that was more than double the company's growth rate: sales were up 109.4% in 2020, from 77.45 million Taiwanese Dollars to 162.16 million Taiwanese Dollars . Not all segments of Abnova (Taiwan) experienced an increase in sales in 2020: sales of Equipment fell 92.1% to 827,000.00 Taiwanese Dollars . (However, this segment's sales were only a very small portion of the company's overall sales). Abnova (Taiwan) also experienced decreases in sales in Monoclonal Antibodies (down 10.6% to 115.04 million Taiwanese Dollars ) and Others (down 2.9% to 88.42 million Taiwanese Dollars ) and Protein (down 12.2% to 56.63 million Taiwanese Dollars ) and Multiple Strains of Antibodies (down 20.6% to 33.37 million Taiwanese Dollars ) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Abnova (Taiwan) Corporation
  Stock Performance Chart for Abnova (Taiwan) Corporation
 
  Stock Data: Recent Stock Performance:
  Current Price (5/14/2021): 61.50
(Figures in Taiwanese Dollars )
1 Week 27.2%   13 Weeks 18.5%  
4 Weeks n/a   52 Weeks 14.5%  
 
Abnova (Taiwan) Corporation Key Data:
  Ticker: 4133 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 456,449,000
(Year Ending Jan 2021).
Employees: 190
  Currency: Taiwanese Dollars Market Cap: 3,724,071,000
  Fiscal Yr Ends: December Shares Outstanding: 60,554,000
  Share Type: Gu Closely Held Shares: 13,291,000
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.